Broad agency announcement to have stable dry formulation of a safe phage preparation that possesses strong antimicrobial efficacy against foodborne bacterial pathogens of concern to the US army,…

Active Definitive Contract Awarded Last action

Contract number
W911QY25C0015
Awardee
Awarding agency
Obligated
$178,777

Award facts

Contract value 72% obligated
  • $178,777.00 Current, with exercised options
  • $249,970.00 Potential, with all options
Completion date 42% complete
Current and potential, with all options
Contracting staff
Funding agency
Research Development and Engineering Command Army Materiel Command, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Firm Fixed Price
Place of performance
Columbia, MD 21046, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Funding Only Action P00004 $98,959
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · Optimize the development and test dry formulation of the phagesafe phage preparation that has potent antimicrobial activity against three major foodborne… $0
Original award $79,818

About this award

The U.S. Army Research Development and Engineering Command awarded a $249,970 definitive contract to Intralytix Inc. on February 13, 2025, to develop and optimize a stable dry formulation of PhageSafe phage preparation with antimicrobial efficacy against foodborne bacterial pathogens including L. monocytogenes, Salmonella, and E. coli STEC.

The contract is firm fixed price with no set-aside. Place of performance is Columbia, MD. Work concludes February 19, 2029. The effort stems from a Broad Agency Announcement soliciting basic and applied research in support of Soldier protection and survivability across multiple technical areas; this award addresses food safety research under Section 831 authority.

Description

Broad agency announcement to have stable dry formulation of a safe phage preparation that possesses strong antimicrobial efficacy against foodborne bacterial pathogens of concern to the US army, such as l. Monocytogenes, salmonella, and e.coli stec.

Quick answers

Who was awarded contract W911QY25C0015?

W911QY25C0015 was awarded to Intralytix Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on February 13, 2025.

How much is contract W911QY25C0015 worth?

The government has obligated $178,777 on W911QY25C0015. Its potential value, with all options, is $249,970.

Which agency awarded contract W911QY25C0015?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY25C0015, with funding from Research Development and Engineering Command (Army Materiel Command).

Was contract W911QY25C0015 competed?

The extent of competition for W911QY25C0015 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award